Skip to content
Federal dataHealth

Oxycodone

Published by U.S. Food and Drug Administration · Updated 03/17/2025 · Yearly

Last updated
03/17/2025
First published 09/16/2016
Update frequency
Yearly
Formats
Web only
Coverage
Nationwide
Federal data

About this dataset

XTAMPZA ER is an extended-release oral capsule containing oxycodone, a prescription opioid agonist used for pain management. Available in strengths from 9 mg to 36 mg, it's manufactured by Collegium Pharmaceutical, Inc., and classified as a DEA Schedule II controlled substance. This information was generated using AI and is provided for informational and research purposes only.

Files and access

Links open the official government source

Links open outside websites we do not control.

Frequently asked questions

Who publishes Oxycodone?
U.S. Food and Drug Administration, part of U.S. Department of Health & Human Services, publishes this dataset on Data.gov.
How often is it updated?
The publisher lists the update frequency as yearly. The last update was on 03/17/2025.
How do I download it?
Use the official source link above to view or request the data.

Similar data from other publishers

Where this catalog comes from

Catalog checked 10/24/2026

We list dataset descriptions only. Downloads and APIs link straight to the official government source, which holds the current version and its terms of use.

Source: Data.gov · Last updated 10/24/2026 · Listing only; the data stays with the publisher